Combined therapy with Fludarabine and Cyclophosphamide in relapsed/resistant patients with B‐cell chronic lymphocytic leukaemia and non‐Hodgkin's lymphomas
- 1 November 1997
- journal article
- Published by Wiley in European Journal of Haematology
- Vol. 59 (5) , 327-328
- https://doi.org/10.1111/j.1600-0609.1997.tb01694.x
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatmentBlood, 1996
- Phase I study of the combination of fludarabine, mitoxantrone, and dexamethasone in low-grade lymphoma.Journal of Clinical Oncology, 1994
- Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment [see comments]Blood, 1993
- Activity of fludarabine in previously treated non-Hodgkin's low-grade lymphoma: results of an Eastern Cooperative Oncology Group study.Journal of Clinical Oncology, 1992
- Fludarabine: a new agent with major activity against chronic lymphocytic leukemiaBlood, 1989